DrugPatentWatch Blog
777 FOLLOWERS
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Business intelligence on pharmaceutical and biologic drugs - patents, generics, pricing, sales, litigation, and more. Make Better Decisions with DrugPatentWatch.
DrugPatentWatch Blog
9h ago
Annual Drug Patent Expirations for MULTRYS Multrys is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There is one patent…
Source ..read more
DrugPatentWatch Blog
9h ago
Annual Drug Patent Expirations for QINLOCK Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. It is available from one supplier. There are twenty-six patents…
Source ..read more
DrugPatentWatch Blog
9h ago
Annual Drug Patent Expirations for TRALEMENT Tralement is a drug marketed by Am Regent and is included in one NDA. It is available from one supplier. There is one patent…
Source ..read more
DrugPatentWatch Blog
9h ago
Annual Drug Patent Expirations for PEDMARK Pedmark is a drug marketed by Fennec Pharms Inc and is included in one NDA. It is available from one supplier. There are four…
Source ..read more
DrugPatentWatch Blog
9h ago
Annual Drug Patent Expirations for RADICAVA+ORS Radicava Ors is a drug marketed by Mitsubishi Tanabe and is included in one NDA. It is available from one supplier. There are four…
Source ..read more
DrugPatentWatch Blog
9h ago
This chart shows the pharmaceutical companies with patents in the most countries. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
Source ..read more
DrugPatentWatch Blog
2d ago
Annual Drug Patent Expirations for AUVELITY Auvelity is a drug marketed by Axsome and is included in one NDA. It is available from one supplier. There are one hundred and…
Source ..read more
DrugPatentWatch Blog
2d ago
Annual Drug Patent Expirations for FABHALTA Fabhalta is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
Source ..read more
DrugPatentWatch Blog
2d ago
DUAVEE (bazedoxifene acetate; estrogens, conjugated) Wyeth pharms Patent: 6,479,535 Expiration: May 6, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
Source ..read more
DrugPatentWatch Blog
2d ago
This chart shows the drugs with the most patents in Slovakia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
Source ..read more